Summary
R-Tech Ueno, Ltd. (R-Tech) is a pharmaceutical company that develops, manufactures and markets products such as RTU-007, RU-101, RTU-1096, UF-021and RK-023. The company offers products in the form of eye drops. It offers products for the treatment of retinitis pigmentosa, dry eye, diabetic cataract, diabetic retinopathy, age-related macular degeneration, alopecia, hypotrichosis of the eyelashes, atopic dermatitis, contact dermatitis, psoriasis and diabetic neuropathy. R-Tech Ueno concentrates on the creation, protection, and utilization of intellectual property. The company offers drug discovery, development support and contract manufacturing services. It operates in Asia and Oceania areas. R-Tech is headquartered in Chiyoda-ku, Japan.
R-Tech Ueno, Ltd. (4573) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
R-Tech Ueno Acquires Rights to DE-105 from Santen Pharma 10
Partnerships 11
R-Tech Ueno Plans to Enter into Research Agreement with UAB and VHIR 11
R-Tech Ueno Enters into Research Agreement with Hokkaido University 12
R-Tech Ueno Enters Into Co-Development Agreement With Keio University School Of Medicine 13
Licensing Agreements 14
Sucampo Pharma Terminates Licensing Agreement with R-Tech Ueno 14
Sucampo Pharma and R-Tech Ueno Enter into Licensing Agreement with Par Pharma 15
R-Tech Ueno Enters Into Licensing Agreement With Kaketsuken 16
Sucampo Extends Licensing Agreement With R-Tech Ueno For RESCULA 17
Mitsubishi Tanabe Pharma Terminates Its Licensing Agreement With R-Tech Ueno 19
R-Tech Ueno Terminates Its Licensing Agreement With Novartis Pharma For The Rights Of Rescula In Europe 20
Acquisition 21
Sucampo Pharma Acquires R-Tech Ueno for USD274.5 Million in Tender Offer 21
R-Tech Ueno, Ltd. - Key Competitors 23
Key Employees 24
Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26
List of Tables
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Key Facts, 2015 1
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
R-Tech Ueno, Ltd., Deals By Therapy Area, 2010 to YTD 2016 8
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
R-Tech Ueno Acquires Rights to DE-105 from Santen Pharma 10
R-Tech Ueno Plans to Enter into Research Agreement with UAB and VHIR 11
R-Tech Ueno Enters into Research Agreement with Hokkaido University 12
R-Tech Ueno Enters Into Co-Development Agreement With Keio University School Of Medicine 13
Sucampo Pharma Terminates Licensing Agreement with R-Tech Ueno 14
Sucampo Pharma and R-Tech Ueno Enter into Licensing Agreement with Par Pharma 15
R-Tech Ueno Enters Into Licensing Agreement With Kaketsuken 16
Sucampo Extends Licensing Agreement With R-Tech Ueno For RESCULA 17
Mitsubishi Tanabe Pharma Terminates Its Licensing Agreement With R-Tech Ueno 19
R-Tech Ueno Terminates Its Licensing Agreement With Novartis Pharma For The Rights Of Rescula In Europe 20
Sucampo Pharma Acquires R-Tech Ueno for USD274.5 Million in Tender Offer 21
R-Tech Ueno, Ltd., Key Competitors 23
R-Tech Ueno, Ltd., Key Employees 24
R-Tech Ueno, Ltd., Other Locations 25
List of Figures
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
R-Tech Ueno, Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8